Ropes & Gray Represents Sanofi in Investment in Enveda’s $150 Million Series C Financing

In The News
February 26, 2025

Ropes & Gray represented Sanofi in its investment in Enveda’s $150 million Series C financing. Enveda is a biotechnology company that uses AI-powered tools to identify and characterize a wide range of molecules produced by living organisms, creating a database of chemical biodiversity.

The Ropes & Gray team included venture capital and emerging companies counsel Michael Connolly, venture capital and emerging companies associate Derek Mubiru, corporate associate Dean Mosley, and venture capital and emerging companies partner Rajarshi Banerjee.